- Tilray Medical, a medical cannabis division of Tilray Brands (NASDAQ:TLRY) has expanded its medical cannabis offerings in the United Kingdom.
- Tilray Medical now offers an extensive selection of medical cannabis products including a market leading portfolio of cannabis flowers with THC potencies that span from 10% to 25% and offer a range of different ratios.
- Tilray Medical supplies the UK and the rest of international business with EU-GMP certified medical cannabis from company's state-of-the-art facilities in Portugal, providing patients with safe and reliable access to high-quality medical cannabis.
- Shares up 1.2% PM.
- The company lost around 82% over a period of one year.